- Home
- Publications
- Publication Search
- Publication Details
Title
Drug transporters and anthracycline-induced cardiotoxicity
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 19, Issue 11, Pages 883-888
Publisher
Future Medicine Ltd
Online
2018-07-11
DOI
10.2217/pgs-2018-0056
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The future role of pharmacogenomics in anticancer agent-induced cardiovascular toxicity
- (2018) Tarek Magdy et al. PHARMACOGENOMICS
- Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction
- (2017) Amandla Atilano-Roque et al. TOXICOLOGY IN VITRO
- Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients
- (2017) Abolfazl Faraji et al. PLoS One
- Organic Cation Transporter–Mediated Clearance of Cardiovascular Drugs
- (2016) Omar T. Hassan et al. AMERICAN JOURNAL OF THERAPEUTICS
- Functional Variant in theSLC22A3-LPAL2-LPAGene Cluster Contributes to the Severity of Coronary Artery DiseaseHighlights
- (2016) Long Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
- (2016) Folefac Aminkeng et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Evidence for association of SNPs inABCB1andCBR3, but notRAC2, NCF4, SLC28A3orTOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
- (2016) Daniel L Hertz et al. PHARMACOGENOMICS
- Effect of Inflammation on Molecular Targets and Drug Transporters
- (2016) Sherif Hanafy et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
- (2016) Emil Andreev et al. Scientific Reports
- Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue
- (2015) Nadia Ayala-Lopez et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters
- (2015) So-Young Chun et al. BIOMEDICINE & PHARMACOTHERAPY
- High-throughput screens in mammalian cells using the CRISPR-Cas9 system
- (2015) Jingyu Peng et al. FEBS Journal
- Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma
- (2015) Annegret Reichwagen et al. PHARMACOGENOMICS
- Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children
- (2015) Henk Visscher et al. PHARMACOGENOMICS
- Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS Cardiomyopathy
- (2015) S. Yamada et al. Journal of the American Heart Association
- Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines
- (2015) Nicolas Brosseau et al. PLoS One
- In vivodisposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters
- (2014) Selvi Durmus et al. INTERNATIONAL JOURNAL OF CANCER
- Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio)
- (2014) Ying Han et al. JOURNAL OF APPLIED TOXICOLOGY
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish
- (2013) A. Hruscha et al. DEVELOPMENT
- Propranolol Transport Across the Inner Blood–Retinal Barrier: Potential Involvement of a Novel Organic Cation Transporter
- (2013) Yoshiyuki Kubo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Regenerative medicine approach to repair the failing heart
- (2013) Vincenzo Lionetti et al. VASCULAR PHARMACOLOGY
- Impact of Genetic Variation in OATP Transporters to Drug Disposition and Response
- (2012) Inna Y. Gong et al. Drug Metabolism and Pharmacokinetics
- Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin
- (2012) C. Jovelet et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action
- (2012) Hao-Jie Zhu et al. PHARMACOLOGICAL RESEARCH
- Role of ABC transporters in cancer chemotherapy
- (2012) Yue-Li Sun et al. Chinese Journal of Cancer
- Selective Regulation of Cardiac Organic Cation Transporter Novel Type 2 (OCTN2) in Dilated Cardiomyopathy
- (2011) Markus Grube et al. AMERICAN JOURNAL OF PATHOLOGY
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
- (2010) Mohamed M. Sayed-Ahmed et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Doxorubicin induces drug efflux pumps inCandida albicans
- (2010) Grzegorz Kofla et al. MEDICAL MYCOLOGY
- The Canadian Pharmacogenomics Network for Drug Safety: A Model for Safety Pharmacology
- (2010) Colin J.D. Ross et al. THYROID
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
- (2009) K K Filipski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interaction of beta-blockers with the renal uptake transporter OCT2
- (2009) I. Bachmakov et al. DIABETES OBESITY & METABOLISM
- The Organic Cation Transporter, OCTN1, Expressed in the Human Heart, Potentiates Antagonism of the HERG Potassium Channel
- (2009) Brian F McBride et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease
- (2009) David-Alexandre Trégouët et al. NATURE GENETICS
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Involvement of Carnitine/organic Cation Transporter OCTN2 (SLC22A5) in Distribution of its Substrate Carnitine to the Heart
- (2008) Daisuke Iwata et al. Drug Metabolism and Pharmacokinetics
- Tissue-specific mRNA Expression Profiles of Human Solute Carrier Transporter Superfamilies
- (2008) Masuhiro Nishimura et al. Drug Metabolism and Pharmacokinetics
- Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
- (2008) M. Okabe et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started